Modulation of mammary cancer cell migration by 15-deoxy-delta(12,14)-prostaglandin J(2): implications for anti-metastatic therapy
A refractory prolactinoma is an adenoma not controlled even by dose escalation to maximally tolerated doses of DA
Related Blog Posts Transforming Lives, One Step at a Time Keep reading Mons Pubis Fat Loss on GLP-1s: The Pubic Area Change Nobody Mentions One change that surprises people on GLP-1 medications rarely comes up in conversation: the mons pubis, the soft fat pad over the pubic bone, How to Adjust Weight Loss Goals on GLP-1 Medications Adjust weight goals on GLP-1 meds by tracking body composition and labs, optimizing protein, activity, sleep, and working with your provider on dosing
To view or add a comment, sign in More Relevant Posts In pharmacokinetic design, systemic administration is highly inefficient when treating localized, acute musculoskeletal inflammation
3.2.1 Observational epidemiologic study of green tea consumption and risk of PD In order to determine the relationship between PD incidence and tea consumption, Quintana et al
Carnitine deficiency, primary Introduction Cardiomyopathy is a serious disease associated with high mortality and morbidity
